The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of triweekly cetuximab in combination with capecitabine as first-line maintenance treatment for KRAS/BRAF wild-type metastatic colorectal cancer: A phase Ib dose-escalation study.
 
Xiaoyu Xie
No Relationships to Disclose
 
Ziqin Lin
No Relationships to Disclose
 
Weiwei Li
No Relationships to Disclose
 
Yuqian Xie
No Relationships to Disclose
 
Jianwei Zhang
No Relationships to Disclose
 
Huabin Hu
No Relationships to Disclose
 
Shanshan Li
No Relationships to Disclose
 
Xiaohui Zhai
No Relationships to Disclose
 
Lishuo Shi
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose